ANH Campaign to Protect Homeopathy: Update

ANH Campaign to Protect Homeopathy: Update

A federal court dismissed ANH’s homeopathy lawsuit on procedural grounds—so we’re taking the fight directly back to the FDA. Listen to the audio version of this article: THE TOPLINE On April 24, 2026, a federal court in Washington, D.C. dismissed ANH-USA and Meditrend’s lawsuit challenging the FDA’s crackdown on homeopathic medicines. Importantly, the court did […]

Read More
Durbin Bill Reappears: New Threat to Supplement Access

Durbin Bill Reappears: New Threat to Supplement Access

A seemingly simple supplement registry could quietly reshape the entire natural health market—and limit what consumers can access. Action Alert! Listen to the audio version of this article: THE TOPLINE Imagine walking into your local health store—or opening your usual online shop—and finding that a supplement you’ve relied on for years is suddenly gone. No […]

Read More
FDA’s Anti-MAHA Stance on Natural Thyroid

FDA’s Anti-MAHA Stance on Natural Thyroid

Patients relying on natural thyroid therapies face renewed uncertainty as the agency doubles down on its impending ban. Action Alert! Listen to the audio version of this article: THE TOPLINE In a late-March statement, the FDA doubled down on its plans to restrict access to natural thyroid treatments. This includes commercial products like Armour Thyroid […]

Read More